Could friendly bacteria help pouch patients poop less?
NCT ID NCT05938465
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new treatment called EXE-346, which is a mix of 8 types of good bacteria. It aims to reduce how often people with an ileal pouch (a surgically created internal reservoir) need to have bowel movements. The trial will enroll 50 adults and first check safety, then see if it actually cuts down on bathroom trips. If successful, it could improve daily life for those with this condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- EXE-346 (a blend of 8 strains of lactic acid bacteria)
- What this could lead to
- If it works, this could offer a new way to reduce frequent bowel movements and improve quality of life for people with an ileal pouch.
- What could go wrong
- This is an early-phase trial with only 50 participants, so results may not apply to everyone. The treatment is a live bacteria product, which carries unknown risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ILEAL POUCH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cedars-Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
-
Corewell Health
RECRUITINGGrand Rapids, Michigan, 49503, United States
-
Mayo Clinic - Florida (Inflammatory Bowel Disease Center)
RECRUITINGJacksonville, Florida, 32224, United States
-
Mayo Clinic Department of Gastroenterology
RECRUITINGRochester, Minnesota, 55905, United States
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
-
Penn State Health (Milton S. Hershey Medical Center)
RECRUITINGHershey, Pennsylvania, 17033, United States
-
University of North Carolina at Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599, United States
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.